Evidence map›Paper›PMID 39416864›Full record

ArticleFrontiers in medicine2024

Myasthenia gravis complicated with pulmonary infection by

Huifen Zuo, Jiaqing Ye, Chenfei Li, Shijie Li, Jingxin Gu, Na Dong, Yihan Zhao, Jiahao Hao, Minghui Song, Yumei Guo and 3 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. A case ofIDCases · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Huifen Zuo *Department of Clinical Laboratory, Hebei Yiling Hospital, Shijiazhuang, China.
Jiaqing Ye *Department of Clinical Laboratory, Hebei Medical University Third Hospital, Shijiazhuang, China.
Chenfei LiDepartment of Orthopedics, Hebei Medical University Third Hospital, Shijiazhuang, China.
Shijie LiDepartment of Myasthenia Gravis, Hebei Yiling Hospital, Shijiazhuang, China.
Jingxin GuDepartment of Clinical Laboratory, Hebei Yiling Hospital, Shijiazhuang, China.
Na DongDepartment of Clinical Laboratory, Hebei Yiling Hospital, Shijiazhuang, China.
Yihan ZhaoDepartment of Clinical Laboratory, Hebei Yiling Hospital, Shijiazhuang, China.
Jiahao HaoDepartment of Clinical Laboratory, Hebei Medical University Third Hospital, Shijiazhuang, China.
Minghui SongDepartment of Clinical Laboratory, Hebei Medical University Third Hospital, Shijiazhuang, China.
Yumei GuoHebei Key Laboratory of Intractable Pathogens, Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang, China.
Weili GaoHebei Key Laboratory of Intractable Pathogens, Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang, China.
Zhenjun ZhaoDepartment of Clinical Laboratory, Hebei Yiling Hospital, Shijiazhuang, China.
Lijie ZhangDepartment of Clinical Laboratory, Hebei Medical University Third Hospital, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myasthenia gravis (MG) is an autoimmune disease. Patients with MG due to compromised autoimmune regulation, progressive muscle weakness, and prolonged use of immunosuppressants and glucocorticoid, often present with concomitant infections. However, cases of MG complicated by

Indexed as

immunosuppressionmyasthenia gravisNocardia cyriacigeorgicapulmonary infectiontrimethoprim-sulfamethoxazole

Identifiers

PMID39416864
PMCPMC11480046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.